Drug Shortage Report for APIDRA

Last updated on 2022-07-19 History
Report ID 163664
Drug Identification Number 02294346
Brand name APIDRA
Common or Proper name Apidra Solostar
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) INSULIN GLULISINE
Strength(s) 100UNIT
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 5
ATC code A10AB
ATC description INSULINS AND ANALOGUES
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2022-07-04
Actual start date 2022-07-07
Estimated end date 2022-08-31
Actual end date
Shortage status Actual shortage
Updated date 2022-07-19
Company comments The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2022-07-19 French Compare
v9 2022-07-19 English Compare
v8 2022-07-11 French Compare
v7 2022-07-11 English Compare
v6 2022-07-05 English Compare
v5 2022-06-29 French Compare
v4 2022-06-29 English Compare
v3 2022-06-29 French Compare
v2 2022-06-29 English Compare
v1 2022-06-29 English Compare

Showing 1 to 10 of 10